NOTICE & PROXY STATEMENT

Company

GT Biopharma, Inc.

Filed

June 9, 1998

Period of Report

July 13, 1998

Accession Number

0000929624-98-001105

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →